[EN] NOVEL P2X7R ANTAGONISTS AND THEIR USE<br/>[FR] NOUVEAUX ANTAGONISTES DE P2X7R ET LEUR UTILISATION
申请人:AFFECTIS PHARMACEUTICALS AG
公开号:WO2009118175A1
公开(公告)日:2009-10-01
The present application is directed to novel P2X7R antagonists that are indol-3-carboxamide or azaindole-3-carboxamide compounds, pharmaceutical compositions comprising the same and their use for the prophylactic or therapeutic treatment of diseases mediated by P2X7R activity. Formula (I) - a, b, c, d, x are at each occurrence independently selected from carbon, or nitrogen.